{"id":117,"date":"2019-09-22T17:54:06","date_gmt":"2019-09-22T21:54:06","guid":{"rendered":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/chapter\/3-14-antivirals\/"},"modified":"2022-03-16T12:53:41","modified_gmt":"2022-03-16T16:53:41","slug":"3-15-antivirals","status":"publish","type":"chapter","link":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/chapter\/3-15-antivirals\/","title":{"raw":"3.15 Antivirals","rendered":"3.15 Antivirals"},"content":{"raw":"[caption id=\"\" align=\"alignnone\" width=\"1200\"]<img title=\"&quot;Unknown&quot; by CNX OpenStax is licensed under CC BY 4.0 Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/1-3-types-of-microorganisms\" src=\"https:\/\/pressbooks.bccampus.ca\/knowinghome\/wp-content\/uploads\/sites\/1167\/2019\/09\/image13.png\" alt=\"Photos of viruses. The first photo shows members of the Coronavirus family. The second photo shows the Ebolavirus, a member of the Filovirus family.\" width=\"1200\" height=\"522\" \/> Figure 3.10 Images of viruses (a) Members of the Coronavirus family can cause respiratory infections like the common cold, severe acute respiratory syndrome (SARS), and Middle East respiratory syndrome (MERS). Here they are viewed under a transmission electron microscope (TEM). (b) Ebolavirus, a member of the Filovirus family. (credit a: modification of work by Centers for Disease Control and Prevention; credit b: modification of work by Thomas W. Geisbert)[\/caption]\r\n\r\nUnlike the complex structure of fungi or protozoa, viral structure is simple.\u00a0 There are several subclasses of antiviral medications: antiherpes, antiinfluenza, anti-hepatitis, and antiretrovirals.\u00a0 Each subclass will be discussed in more detail below.\u00a0 See Figure 3.10[footnote]\"Unknown\" by <a href=\"https:\/\/cnx.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">CNX OpenStax<\/a> is licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a> Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-3-types-of-microorganisms\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-3-types-of-microorganisms<\/a>[\/footnote] for images of viruses.\r\n<h2>Subclass: Antiherpes<\/h2>\r\n<strong>Indications for Use: <\/strong>Acyclovir (Zovirax) and its derivatives are frequently used for the treatment of herpes and varicella virus infections, including genital herpes, chickenpox, shingles, Epstein-Barr virus infections, and cytomegalovirus infections.\r\n\r\n<strong>Mechanism of Action:<\/strong> Acyclovir causes termination of the DNA chain during the viral replication process. Acyclovir can be administered either topically or systemically, depending on the infection.<sup>[footnote]This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a>[\/footnote]<\/sup>\r\n\r\n<strong>Special Administration Considerations:<\/strong> Acyclovir use may result in nephrotoxicity.\r\n\r\n<strong>Client Teaching &amp; Education:<\/strong> Clients who are being treated with antiviral therapy should be instructed about the importance of medication compliance. They may also experience significant fatigue, so periods of rest should be encouraged.<sup>[footnote]uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a>[\/footnote]<\/sup>\r\n<h2>Subclass: AntiInfluenza<\/h2>\r\n<strong>Indications for Use: <\/strong>Tamiflu (oseltamivir) is used to target the influenza virus by blocking the release of the virus from the infected cells.\r\n\r\n<strong>Mechanism of Action:<\/strong> Tamiflu prevents the release of virus from infected cells.\r\n\r\n<strong>Special Administration Considerations:<\/strong> This medication does not cure influenza, but can decrease flu symptoms and shorten the duration of illness if taken in a timely manner. Ckients are prescribed the medication for prophylaxis against infection, known exposure, or to lesson the course of the illness. If clients experience flu-like symptoms, it is critical that they start treatment within 48 hours of symptom onset.\r\n\r\n<strong>Client Teaching &amp; Education:<\/strong> Clients who are being treated with antiviral therapy should be instructed about the importance of medication compliance. They may also experience significant fatigue, so periods of rest should be encouraged.<sup>[footnote]uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a>[\/footnote]<\/sup>\r\n\r\nThe influenza virus is one of the few RNA viruses that replicates in the nucleus of cells. Antivirals block the release stage. See Figure 3.11.<sup>[footnote]\"Unknown\" by <a href=\"https:\/\/cnx.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">CNX OpenStax<\/a> is licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a> Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/6-2-the-viral-life-cycle\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/6-2-the-viral-life-cycle<\/a>[\/footnote]<\/sup>\r\n\r\n[caption id=\"attachment_116\" align=\"aligncenter\" width=\"1024\"]<img class=\"wp-image-115 size-large\" title=\"&quot;Unknown&quot; by CNX OpenStax is licensed under CC BY 4.0 Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/6-2-the-viral-life-cycle CC BY 4.0\" src=\"https:\/\/pressbooks.bccampus.ca\/knowinghome\/wp-content\/uploads\/sites\/1167\/2020\/10\/Influenza-Virus-1024x876.png\" alt=\"Illustration of Influenza virus attaching to target cell and replication within nucleus of cells.\" width=\"1024\" height=\"876\" \/> Figure 3.11 Influenza virus replication stages[\/caption]\r\n<h2>Subclass: Antiretrovirals<\/h2>\r\nViruses with complex life cycles, such as HIV, can be more difficult to treat. These types of viruses require the use of antiretroviral medications that block viral replication. (See Figure 3.12 to view the viral replication process of HIV.)<span style=\"font-size: 12.8px\"><sup> [footnote]This work is a derivative of \"<a href=\"https:\/\/www.flickr.com\/photos\/niaid\/5057022555\/in\/album-72157625994990013\/\" target=\"_blank\" rel=\"noopener noreferrer\">HIV Virus Replication Cycle<\/a>\" by <a href=\"https:\/\/www.flickr.com\/photos\/niaid\/\" target=\"_blank\" rel=\"noopener noreferrer\">NIAID<\/a> is licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/2.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 2.0<\/a>[\/footnote]<\/sup>\u00a0<\/span>Additionally, antiretrovirals fall under the class of antiviral medications.\r\n\r\n[caption id=\"attachment_116\" align=\"aligncenter\" width=\"406\"]<img class=\"wp-image-116 size-full\" title=\"This work is a derivative of &quot;HIV Virus Replication Cycle&quot; by NIAID, https:\/\/www.flickr.com\/photos\/niaid\/5057022555\/in\/album-72157625994990013\/, licensed under CC BY 2.0\" src=\"https:\/\/pressbooks.bccampus.ca\/knowinghome\/wp-content\/uploads\/sites\/1167\/2020\/10\/HIV-and-surface-cell-receptor.png\" alt=\"Illustration with labels showing HIV attached to cell surface receptor\" width=\"406\" height=\"512\" \/> Figure 3.12 HIV attaches to a cell surface receptor of an immune cell and fuses with the cell membrane. Viral contents are released into the cell, where viral enzymes convert the single-stranded RNA genome into DNA and incorporate it into the host genome[\/caption]\r\n\r\n<strong>Indications for Use:<\/strong> Antiretrovirals are used for the treatment of illnesses like HIV.\r\n\r\n<strong>Mechanism of Action:<\/strong> Antiretrovirals impede virus replication.\r\n\r\n<strong>Special Administration Considerations:<\/strong>\u00a0 Many antiretrovirals may impact renal function; therefore, the client's urine output and renal labs should be monitored carefully for signs of decreased function.\r\n\r\n<strong>Client Teaching &amp; Education:<\/strong> Clients who are being treated with antiviral therapy should be instructed about the importance of antiretroviral compliance. They may also experience significant fatigue, so periods of rest should be encouraged.<sup>[footnote]uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a>[\/footnote]<\/sup>\r\n\r\nNow let's take a closer look at the medication cards for the subclasses of antivirals in Table 3.14a-d.<sup>[footnote]Daily Med, <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/index.cfm\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/dailymed.nlm.nih.gov\/dailymed\/index.cfm<\/a>, used for hyperlinked medications in this module. Retrieved June 27, 2019[\/footnote]<\/sup>[footnote]UpToDate (2021). <em>Acyclovir<\/em>. <a href=\"https:\/\/www.uptodate.com\/contents\/search\">https:\/\/www.uptodate.com\/contents\/search<\/a>[\/footnote][footnote]UpToDate (2021). <em>Oseltamivir<\/em>. <a href=\"https:\/\/www.uptodate.com\/contents\/search\">https:\/\/www.uptodate.com\/contents\/search<\/a>[\/footnote][footnote]UpToDate (2021). <em>Adefovir<\/em>. <a href=\"https:\/\/www.uptodate.com\/contents\/search\">https:\/\/www.uptodate.com\/contents\/search<\/a>[\/footnote][footnote]UpToDate (2021). <em>Lamivudine-Zidovudine.<\/em> <a href=\"https:\/\/www.uptodate.com\/contents\/search\">https:\/\/www.uptodate.com\/contents\/search<\/a>[\/footnote] Because information about medication is constantly changing, nurses should always consult evidence-based resources to review current recommendations before administering specific medication.\r\n\r\nTables 3.14a Acyclovir Medication Card\r\n\r\n<strong>Class\/Subclass:\u00a0 Antivirals\/Antiherpes<\/strong> (prototype:\u00a0 <a class=\"rId56\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=d13b8cdd-59fd-472b-8125-a19f42ef5402&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\">acyclovir<\/a>)\r\n\r\n<img class=\"aligncenter wp-image-976 size-full\" src=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiherpes-scaled.jpg\" alt=\"Anti-herpes drug card\" width=\"2560\" height=\"855\" \/>\r\n\r\nTables 3.14b Oseltamivir Medication Card\r\n\r\n<strong>Class\/Subclass:\u00a0 Antivirals\/Anti-Influenza Agents<\/strong> (prototype:\u00a0 <a class=\"rId57\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=82685c2f-791b-440f-a1c2-5a032da7adca&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\">oseltamivir<\/a>)\r\n\r\n<img class=\"aligncenter wp-image-977 size-full\" src=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiflu-scaled.jpg\" alt=\"Anti-influenza agent drug card\" width=\"2560\" height=\"768\" \/>\r\n\r\nTables 3.14c Adefovir Medication Card\r\n\r\n<strong>Class\/Subclass:\u00a0 Antivirals\/Anti-Hepatitis Agents<\/strong> (prototype: <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=80595d45-2224-47d1-bd5c-4b11a824e5bd&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\">adefovir<\/a>)\r\n\r\n<img class=\"aligncenter wp-image-980 size-full\" src=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antihepatitis-scaled.jpg\" alt=\"Anti-hepatitis agent drug card\" width=\"2560\" height=\"770\" \/>\r\n\r\nTables 3.14d Lamuvadine-Zidovudine Medication Card\r\n\r\n<strong>Class\/Subclass:\u00a0 Antivirals\/Anti-retrovirals<\/strong> (prototype:\u00a0 <a class=\"rId59\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=da2d3a56-a124-46cd-93bf-82b3c419536b&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\">lamivudine- zidovudine<\/a>)\r\n\r\n<img class=\"aligncenter wp-image-981 size-full\" src=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiretrovirals-scaled.jpg\" alt=\"Antiretroviral drug card\" width=\"2560\" height=\"901\" \/>\r\n<div class=\"textbox textbox--examples\"><header class=\"textbox__header\">\r\n<h2><strong>Clinical Reasoning and Decision-Making Activity 3.14<\/strong><\/h2>\r\n<\/header>\r\n<div class=\"textbox__content\">\r\n\r\n<strong>Using the above information, consider the following clinical scenario question:<\/strong>\r\n\r\nA client is prescribed oseltamivir (Tamiflu) for influenza symptoms. The client states to the nurse, \"I hope this medication works quickly! I have felt lousy for the past 5 days!\" What is the nurse's next best response?\r\n\r\nNote: Answers to the activities can be found in the \"<a href=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/chapter\/chapter-3\/\">Answer Key<\/a>\" sections at the end of the book.\r\n\r\n<\/div>\r\n<\/div>\r\n&nbsp;","rendered":"<figure style=\"width: 1200px\" class=\"wp-caption alignnone\"><img loading=\"lazy\" decoding=\"async\" title=\"&quot;Unknown&quot; by CNX OpenStax is licensed under CC BY 4.0 Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/1-3-types-of-microorganisms\" src=\"https:\/\/pressbooks.bccampus.ca\/knowinghome\/wp-content\/uploads\/sites\/1167\/2019\/09\/image13.png\" alt=\"Photos of viruses. The first photo shows members of the Coronavirus family. The second photo shows the Ebolavirus, a member of the Filovirus family.\" width=\"1200\" height=\"522\" \/><figcaption class=\"wp-caption-text\">Figure 3.10 Images of viruses (a) Members of the Coronavirus family can cause respiratory infections like the common cold, severe acute respiratory syndrome (SARS), and Middle East respiratory syndrome (MERS). Here they are viewed under a transmission electron microscope (TEM). (b) Ebolavirus, a member of the Filovirus family. (credit a: modification of work by Centers for Disease Control and Prevention; credit b: modification of work by Thomas W. Geisbert)<\/figcaption><\/figure>\n<p>Unlike the complex structure of fungi or protozoa, viral structure is simple.\u00a0 There are several subclasses of antiviral medications: antiherpes, antiinfluenza, anti-hepatitis, and antiretrovirals.\u00a0 Each subclass will be discussed in more detail below.\u00a0 See Figure 3.10<a class=\"footnote\" title=\"&quot;Unknown&quot; by CNX OpenStax is licensed under CC BY 4.0 Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/1-3-types-of-microorganisms\" id=\"return-footnote-117-1\" href=\"#footnote-117-1\" aria-label=\"Footnote 1\"><sup class=\"footnote\">[1]<\/sup><\/a> for images of viruses.<\/p>\n<h2>Subclass: Antiherpes<\/h2>\n<p><strong>Indications for Use: <\/strong>Acyclovir (Zovirax) and its derivatives are frequently used for the treatment of herpes and varicella virus infections, including genital herpes, chickenpox, shingles, Epstein-Barr virus infections, and cytomegalovirus infections.<\/p>\n<p><strong>Mechanism of Action:<\/strong> Acyclovir causes termination of the DNA chain during the viral replication process. Acyclovir can be administered either topically or systemically, depending on the infection.<sup><a class=\"footnote\" title=\"This work is a derivative of Microbiology by OpenStax licensed under CC BY 4.0. Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" id=\"return-footnote-117-2\" href=\"#footnote-117-2\" aria-label=\"Footnote 2\"><sup class=\"footnote\">[2]<\/sup><\/a><\/sup><\/p>\n<p><strong>Special Administration Considerations:<\/strong> Acyclovir use may result in nephrotoxicity.<\/p>\n<p><strong>Client Teaching &amp; Education:<\/strong> Clients who are being treated with antiviral therapy should be instructed about the importance of medication compliance. They may also experience significant fatigue, so periods of rest should be encouraged.<sup><a class=\"footnote\" title=\"uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral\" id=\"return-footnote-117-3\" href=\"#footnote-117-3\" aria-label=\"Footnote 3\"><sup class=\"footnote\">[3]<\/sup><\/a><\/sup><\/p>\n<h2>Subclass: AntiInfluenza<\/h2>\n<p><strong>Indications for Use: <\/strong>Tamiflu (oseltamivir) is used to target the influenza virus by blocking the release of the virus from the infected cells.<\/p>\n<p><strong>Mechanism of Action:<\/strong> Tamiflu prevents the release of virus from infected cells.<\/p>\n<p><strong>Special Administration Considerations:<\/strong> This medication does not cure influenza, but can decrease flu symptoms and shorten the duration of illness if taken in a timely manner. Ckients are prescribed the medication for prophylaxis against infection, known exposure, or to lesson the course of the illness. If clients experience flu-like symptoms, it is critical that they start treatment within 48 hours of symptom onset.<\/p>\n<p><strong>Client Teaching &amp; Education:<\/strong> Clients who are being treated with antiviral therapy should be instructed about the importance of medication compliance. They may also experience significant fatigue, so periods of rest should be encouraged.<sup><a class=\"footnote\" title=\"uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral\" id=\"return-footnote-117-4\" href=\"#footnote-117-4\" aria-label=\"Footnote 4\"><sup class=\"footnote\">[4]<\/sup><\/a><\/sup><\/p>\n<p>The influenza virus is one of the few RNA viruses that replicates in the nucleus of cells. Antivirals block the release stage. See Figure 3.11.<sup><a class=\"footnote\" title=\"&quot;Unknown&quot; by CNX OpenStax is licensed under CC BY 4.0 Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/6-2-the-viral-life-cycle\" id=\"return-footnote-117-5\" href=\"#footnote-117-5\" aria-label=\"Footnote 5\"><sup class=\"footnote\">[5]<\/sup><\/a><\/sup><\/p>\n<figure id=\"attachment_116\" aria-describedby=\"caption-attachment-116\" style=\"width: 1024px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-115 size-large\" title=\"&quot;Unknown&quot; by CNX OpenStax is licensed under CC BY 4.0 Access for free at https:\/\/openstax.org\/books\/microbiology\/pages\/6-2-the-viral-life-cycle CC BY 4.0\" src=\"https:\/\/pressbooks.bccampus.ca\/knowinghome\/wp-content\/uploads\/sites\/1167\/2020\/10\/Influenza-Virus-1024x876.png\" alt=\"Illustration of Influenza virus attaching to target cell and replication within nucleus of cells.\" width=\"1024\" height=\"876\" srcset=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2020\/10\/Influenza-Virus-1024x876.png 1024w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2020\/10\/Influenza-Virus-300x257.png 300w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2020\/10\/Influenza-Virus-768x657.png 768w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2020\/10\/Influenza-Virus-65x56.png 65w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2020\/10\/Influenza-Virus-225x192.png 225w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2020\/10\/Influenza-Virus-350x299.png 350w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2020\/10\/Influenza-Virus.png 1290w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><figcaption id=\"caption-attachment-116\" class=\"wp-caption-text\">Figure 3.11 Influenza virus replication stages<\/figcaption><\/figure>\n<h2>Subclass: Antiretrovirals<\/h2>\n<p>Viruses with complex life cycles, such as HIV, can be more difficult to treat. These types of viruses require the use of antiretroviral medications that block viral replication. (See Figure 3.12 to view the viral replication process of HIV.)<span style=\"font-size: 12.8px\"><sup> <a class=\"footnote\" title=\"This work is a derivative of &quot;HIV Virus Replication Cycle&quot; by NIAID is licensed under CC BY 2.0\" id=\"return-footnote-117-6\" href=\"#footnote-117-6\" aria-label=\"Footnote 6\"><sup class=\"footnote\">[6]<\/sup><\/a><\/sup>\u00a0<\/span>Additionally, antiretrovirals fall under the class of antiviral medications.<\/p>\n<figure id=\"attachment_116\" aria-describedby=\"caption-attachment-116\" style=\"width: 406px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-116 size-full\" title=\"This work is a derivative of &quot;HIV Virus Replication Cycle&quot; by NIAID, https:\/\/www.flickr.com\/photos\/niaid\/5057022555\/in\/album-72157625994990013\/, licensed under CC BY 2.0\" src=\"https:\/\/pressbooks.bccampus.ca\/knowinghome\/wp-content\/uploads\/sites\/1167\/2020\/10\/HIV-and-surface-cell-receptor.png\" alt=\"Illustration with labels showing HIV attached to cell surface receptor\" width=\"406\" height=\"512\" srcset=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2020\/10\/HIV-and-surface-cell-receptor.png 406w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2020\/10\/HIV-and-surface-cell-receptor-238x300.png 238w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2020\/10\/HIV-and-surface-cell-receptor-65x82.png 65w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2020\/10\/HIV-and-surface-cell-receptor-225x284.png 225w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2020\/10\/HIV-and-surface-cell-receptor-350x441.png 350w\" sizes=\"auto, (max-width: 406px) 100vw, 406px\" \/><figcaption id=\"caption-attachment-116\" class=\"wp-caption-text\">Figure 3.12 HIV attaches to a cell surface receptor of an immune cell and fuses with the cell membrane. Viral contents are released into the cell, where viral enzymes convert the single-stranded RNA genome into DNA and incorporate it into the host genome<\/figcaption><\/figure>\n<p><strong>Indications for Use:<\/strong> Antiretrovirals are used for the treatment of illnesses like HIV.<\/p>\n<p><strong>Mechanism of Action:<\/strong> Antiretrovirals impede virus replication.<\/p>\n<p><strong>Special Administration Considerations:<\/strong>\u00a0 Many antiretrovirals may impact renal function; therefore, the client&#8217;s urine output and renal labs should be monitored carefully for signs of decreased function.<\/p>\n<p><strong>Client Teaching &amp; Education:<\/strong> Clients who are being treated with antiviral therapy should be instructed about the importance of antiretroviral compliance. They may also experience significant fatigue, so periods of rest should be encouraged.<sup><a class=\"footnote\" title=\"uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral\" id=\"return-footnote-117-7\" href=\"#footnote-117-7\" aria-label=\"Footnote 7\"><sup class=\"footnote\">[7]<\/sup><\/a><\/sup><\/p>\n<p>Now let&#8217;s take a closer look at the medication cards for the subclasses of antivirals in Table 3.14a-d.<sup><a class=\"footnote\" title=\"Daily Med, https:\/\/dailymed.nlm.nih.gov\/dailymed\/index.cfm, used for hyperlinked medications in this module. Retrieved June 27, 2019\" id=\"return-footnote-117-8\" href=\"#footnote-117-8\" aria-label=\"Footnote 8\"><sup class=\"footnote\">[8]<\/sup><\/a><\/sup><a class=\"footnote\" title=\"UpToDate (2021). Acyclovir. https:\/\/www.uptodate.com\/contents\/search\" id=\"return-footnote-117-9\" href=\"#footnote-117-9\" aria-label=\"Footnote 9\"><sup class=\"footnote\">[9]<\/sup><\/a><a class=\"footnote\" title=\"UpToDate (2021). Oseltamivir. https:\/\/www.uptodate.com\/contents\/search\" id=\"return-footnote-117-10\" href=\"#footnote-117-10\" aria-label=\"Footnote 10\"><sup class=\"footnote\">[10]<\/sup><\/a><a class=\"footnote\" title=\"UpToDate (2021). Adefovir. https:\/\/www.uptodate.com\/contents\/search\" id=\"return-footnote-117-11\" href=\"#footnote-117-11\" aria-label=\"Footnote 11\"><sup class=\"footnote\">[11]<\/sup><\/a><a class=\"footnote\" title=\"UpToDate (2021). Lamivudine-Zidovudine. https:\/\/www.uptodate.com\/contents\/search\" id=\"return-footnote-117-12\" href=\"#footnote-117-12\" aria-label=\"Footnote 12\"><sup class=\"footnote\">[12]<\/sup><\/a> Because information about medication is constantly changing, nurses should always consult evidence-based resources to review current recommendations before administering specific medication.<\/p>\n<p>Tables 3.14a Acyclovir Medication Card<\/p>\n<p><strong>Class\/Subclass:\u00a0 Antivirals\/Antiherpes<\/strong> (prototype:\u00a0 <a class=\"rId56\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=d13b8cdd-59fd-472b-8125-a19f42ef5402&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\">acyclovir<\/a>)<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-976 size-full\" src=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiherpes-scaled.jpg\" alt=\"Anti-herpes drug card\" width=\"2560\" height=\"855\" srcset=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiherpes-scaled.jpg 2560w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiherpes-300x100.jpg 300w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiherpes-1024x342.jpg 1024w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiherpes-768x257.jpg 768w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiherpes-1536x513.jpg 1536w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiherpes-2048x684.jpg 2048w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiherpes-65x22.jpg 65w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiherpes-225x75.jpg 225w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiherpes-350x117.jpg 350w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/><\/p>\n<p>Tables 3.14b Oseltamivir Medication Card<\/p>\n<p><strong>Class\/Subclass:\u00a0 Antivirals\/Anti-Influenza Agents<\/strong> (prototype:\u00a0 <a class=\"rId57\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=82685c2f-791b-440f-a1c2-5a032da7adca&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\">oseltamivir<\/a>)<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-977 size-full\" src=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiflu-scaled.jpg\" alt=\"Anti-influenza agent drug card\" width=\"2560\" height=\"768\" srcset=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiflu-scaled.jpg 2560w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiflu-300x90.jpg 300w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiflu-1024x307.jpg 1024w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiflu-768x230.jpg 768w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiflu-1536x461.jpg 1536w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiflu-2048x614.jpg 2048w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiflu-65x19.jpg 65w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiflu-225x67.jpg 225w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiflu-350x105.jpg 350w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/><\/p>\n<p>Tables 3.14c Adefovir Medication Card<\/p>\n<p><strong>Class\/Subclass:\u00a0 Antivirals\/Anti-Hepatitis Agents<\/strong> (prototype: <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=80595d45-2224-47d1-bd5c-4b11a824e5bd&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\">adefovir<\/a>)<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-980 size-full\" src=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antihepatitis-scaled.jpg\" alt=\"Anti-hepatitis agent drug card\" width=\"2560\" height=\"770\" srcset=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antihepatitis-scaled.jpg 2560w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antihepatitis-300x90.jpg 300w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antihepatitis-1024x308.jpg 1024w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antihepatitis-768x231.jpg 768w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antihepatitis-1536x462.jpg 1536w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antihepatitis-2048x616.jpg 2048w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antihepatitis-65x20.jpg 65w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antihepatitis-225x68.jpg 225w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antihepatitis-350x105.jpg 350w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/><\/p>\n<p>Tables 3.14d Lamuvadine-Zidovudine Medication Card<\/p>\n<p><strong>Class\/Subclass:\u00a0 Antivirals\/Anti-retrovirals<\/strong> (prototype:\u00a0 <a class=\"rId59\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=da2d3a56-a124-46cd-93bf-82b3c419536b&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\">lamivudine- zidovudine<\/a>)<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-981 size-full\" src=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiretrovirals-scaled.jpg\" alt=\"Antiretroviral drug card\" width=\"2560\" height=\"901\" srcset=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiretrovirals-scaled.jpg 2560w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiretrovirals-300x106.jpg 300w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiretrovirals-1024x360.jpg 1024w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiretrovirals-768x270.jpg 768w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiretrovirals-1536x540.jpg 1536w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiretrovirals-2048x720.jpg 2048w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiretrovirals-65x23.jpg 65w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiretrovirals-225x79.jpg 225w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/09\/antiretrovirals-350x123.jpg 350w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/><\/p>\n<div class=\"textbox textbox--examples\">\n<header class=\"textbox__header\">\n<h2><strong>Clinical Reasoning and Decision-Making Activity 3.14<\/strong><\/h2>\n<\/header>\n<div class=\"textbox__content\">\n<p><strong>Using the above information, consider the following clinical scenario question:<\/strong><\/p>\n<p>A client is prescribed oseltamivir (Tamiflu) for influenza symptoms. The client states to the nurse, &#8220;I hope this medication works quickly! I have felt lousy for the past 5 days!&#8221; What is the nurse&#8217;s next best response?<\/p>\n<p>Note: Answers to the activities can be found in the &#8220;<a href=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/chapter\/chapter-3\/\">Answer Key<\/a>&#8221; sections at the end of the book.<\/p>\n<\/div>\n<\/div>\n<p>&nbsp;<\/p>\n<div class=\"media-attributions clear\" prefix:cc=\"http:\/\/creativecommons.org\/ns#\" prefix:dc=\"http:\/\/purl.org\/dc\/terms\/\"><h2>Media Attributions<\/h2><ul><li about=\"https:\/\/openstax.org\/books\/microbiology\/pages\/6-2-the-viral-life-cycle\"><a rel=\"cc:attributionURL\" href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/6-2-the-viral-life-cycle\" property=\"dc:title\">Influenza Virus<\/a>       <\/li><li about=\"https:\/\/openstax.org\/books\/microbiology\/pages\/6-2-the-viral-life-cycle)\"><a rel=\"cc:attributionURL\" href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/6-2-the-viral-life-cycle)\" property=\"dc:title\">HIV and surface cell receptor<\/a>  &copy;  NIAID, NIH     <\/li><li >antiherpes       <\/li><li >antiflu       <\/li><li >antihepatitis       <\/li><li >antiretrovirals       <\/li><\/ul><\/div><hr class=\"before-footnotes clear\" \/><div class=\"footnotes\"><ol><li id=\"footnote-117-1\">\"Unknown\" by <a href=\"https:\/\/cnx.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">CNX OpenStax<\/a> is licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a> Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-3-types-of-microorganisms\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-3-types-of-microorganisms<\/a> <a href=\"#return-footnote-117-1\" class=\"return-footnote\" aria-label=\"Return to footnote 1\">&crarr;<\/a><\/li><li id=\"footnote-117-2\">This work is a derivative of <a href=\"https:\/\/cnx.org\/contents\/5CvTdmJL@7.1:rFziotaH@5\/Introduction\" target=\"_blank\" rel=\"noopener noreferrer\">Microbiology<\/a> by <a href=\"https:\/\/openstax.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">OpenStax<\/a> licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a>. Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/1-introduction<\/a> <a href=\"#return-footnote-117-2\" class=\"return-footnote\" aria-label=\"Return to footnote 2\">&crarr;<\/a><\/li><li id=\"footnote-117-3\">uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a> <a href=\"#return-footnote-117-3\" class=\"return-footnote\" aria-label=\"Return to footnote 3\">&crarr;<\/a><\/li><li id=\"footnote-117-4\">uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a> <a href=\"#return-footnote-117-4\" class=\"return-footnote\" aria-label=\"Return to footnote 4\">&crarr;<\/a><\/li><li id=\"footnote-117-5\">\"Unknown\" by <a href=\"https:\/\/cnx.org\/\" target=\"_blank\" rel=\"noopener noreferrer\">CNX OpenStax<\/a> is licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/4.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 4.0<\/a> Access for free at <a href=\"https:\/\/openstax.org\/books\/microbiology\/pages\/6-2-the-viral-life-cycle\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/openstax.org\/books\/microbiology\/pages\/6-2-the-viral-life-cycle<\/a> <a href=\"#return-footnote-117-5\" class=\"return-footnote\" aria-label=\"Return to footnote 5\">&crarr;<\/a><\/li><li id=\"footnote-117-6\">This work is a derivative of \"<a href=\"https:\/\/www.flickr.com\/photos\/niaid\/5057022555\/in\/album-72157625994990013\/\" target=\"_blank\" rel=\"noopener noreferrer\">HIV Virus Replication Cycle<\/a>\" by <a href=\"https:\/\/www.flickr.com\/photos\/niaid\/\" target=\"_blank\" rel=\"noopener noreferrer\">NIAID<\/a> is licensed under <a href=\"https:\/\/creativecommons.org\/licenses\/by\/2.0\/\" target=\"_blank\" rel=\"noopener noreferrer\">CC BY 2.0<\/a> <a href=\"#return-footnote-117-6\" class=\"return-footnote\" aria-label=\"Return to footnote 6\">&crarr;<\/a><\/li><li id=\"footnote-117-7\">uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a> <a href=\"#return-footnote-117-7\" class=\"return-footnote\" aria-label=\"Return to footnote 7\">&crarr;<\/a><\/li><li id=\"footnote-117-8\">Daily Med, <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/index.cfm\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/dailymed.nlm.nih.gov\/dailymed\/index.cfm<\/a>, used for hyperlinked medications in this module. Retrieved June 27, 2019 <a href=\"#return-footnote-117-8\" class=\"return-footnote\" aria-label=\"Return to footnote 8\">&crarr;<\/a><\/li><li id=\"footnote-117-9\">UpToDate (2021). <em>Acyclovir<\/em>. <a href=\"https:\/\/www.uptodate.com\/contents\/search\">https:\/\/www.uptodate.com\/contents\/search<\/a> <a href=\"#return-footnote-117-9\" class=\"return-footnote\" aria-label=\"Return to footnote 9\">&crarr;<\/a><\/li><li id=\"footnote-117-10\">UpToDate (2021). <em>Oseltamivir<\/em>. <a href=\"https:\/\/www.uptodate.com\/contents\/search\">https:\/\/www.uptodate.com\/contents\/search<\/a> <a href=\"#return-footnote-117-10\" class=\"return-footnote\" aria-label=\"Return to footnote 10\">&crarr;<\/a><\/li><li id=\"footnote-117-11\">UpToDate (2021). <em>Adefovir<\/em>. <a href=\"https:\/\/www.uptodate.com\/contents\/search\">https:\/\/www.uptodate.com\/contents\/search<\/a> <a href=\"#return-footnote-117-11\" class=\"return-footnote\" aria-label=\"Return to footnote 11\">&crarr;<\/a><\/li><li id=\"footnote-117-12\">UpToDate (2021). <em>Lamivudine-Zidovudine.<\/em> <a href=\"https:\/\/www.uptodate.com\/contents\/search\">https:\/\/www.uptodate.com\/contents\/search<\/a> <a href=\"#return-footnote-117-12\" class=\"return-footnote\" aria-label=\"Return to footnote 12\">&crarr;<\/a><\/li><\/ol><\/div>","protected":false},"author":103,"menu_order":15,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":["open-resources-for-nursing-open-rn"],"pb_section_license":""},"chapter-type":[48],"contributor":[68],"license":[],"class_list":["post-117","chapter","type-chapter","status-publish","hentry","chapter-type-numberless","contributor-open-resources-for-nursing-open-rn"],"part":78,"_links":{"self":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/117","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/users\/103"}],"version-history":[{"count":9,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/117\/revisions"}],"predecessor-version":[{"id":2612,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/117\/revisions\/2612"}],"part":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/78"}],"metadata":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/117\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/media?parent=117"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=117"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/contributor?post=117"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/license?post=117"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}